Hints and tips:
Related Special Reports
...Ogilvy, which has previously worked with a host of pharma groups including Pfizer and Johnson & Johnson, is launching a business that offers vetted influencers to talk about illnesses and possible solutions...
...It has also worked on drug development for US pharma company Johnson & Johnson, Danish biotech group Genmab and British biotech Iksuda therapeutics....
...They can’t refinance it on a like-for-like basis. But they have the money to refinance it and get more time. I think that is really the story,” said Ramzi Kattan at Moody’s Ratings....
...Johnson & Johnson has offered an improved $6.5bn settlement to tens of thousands of plaintiffs claiming that its talcum powder products caused ovarian cancer, in its latest attempt to draw a line under the...
...Johnson & Johnson will ask tens of thousands of plaintiffs claiming the drugmaker’s baby powder and talc-based products led to ovarian cancer to vote in favour of an improved $6.5bn settlement deal, in its...
...Johnson & Johnson has struck a deal to buy medical device maker Shockwave Medical for $13.1bn, as the healthcare giant pursues acquisitions to bolster its medical technology arm....
...Johnson & Johnson has struck a deal to buy medical device maker Shockwave Medical for $13.1bn, as the healthcare giant puts cash to work from the spin-off of its consumer health arm to pursue acquisitions...
...Michela Tindera Oliver tried to interview him as he reported on this story for the FT, but Eshelman said he couldn’t comment on an active case....
...I’m Rob Armstrong in New York and I’m joined today by Josh Oliver in London....
...They are the ones who the banks didn’t lend to or don’t want to refinance,” said Lisa Attenborough, head of debt advisory at Knight Frank....
...And while summary statistics don’t tell especially colourful stories, they do suggest their outline....
...Lord Eric Pickles, chair of the Advisory Committee on Business Appointments, reported the breach in a letter to deputy prime minister Oliver Dowden on Friday....
...Oliver Roeder is the FT’s US senior data journalist Cartography by Steven Bernard and Sam Learner....
...“It won’t go down, but it won’t go up,” says Steve, who chose a 25-year loan and who asked the FT not to use his real name....
...“When I inherited the money, my instinct was, like, ‘I shouldn’t have this’,” he says....
...“We can’t build houses,” said Clare Miller, chief executive of Clarion, the UK’s largest housing association, which manages 125,000 homes....
...Oliver Leith cheerfully maintains that he writes music the wrong way. “My approach is totally magpie-ish. Anything goes....
...However, Johnson avoided censure. Deputy prime minister Oliver Dowden told the appointments watchdog that it would be “disproportionate to undertake further action”....
...oliver.ralph@ft.com...
...“I don’t know what to think about my exhibition, because I haven’t seen it yet....
...But he said it “hasn’t really taken off” until now, which he credited to “post-pandemic hybrid working patterns”....
...Spravato, a nasal spray based on a molecule from the psychedelic drug ketamine used to treat depression, already ranks as Johnson & Johnson’s fastest-growing product....
...Reputational changes don’t always happen overnight. Often it’s just little by little until there’s not much left....
...But the term has so many emotional connotations that most people don’t link it to delivering business value,” he says....
...High demand for weight-loss drugs has helped Novo Nordisk become Europe’s largest company by market capitalisation, while Eli Lilly overtook Johnson & Johnson as the world’s largest pharmaceutical company...
International Edition